vTv Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Market Capitalization	58	30	69	90	137	102	108	197	158	223	-
Market Cap Growth	-	-56.62%	-22.63%	-34.81%	34.94%	-5.69%	-45.25%	24.43%	-29.07%	-	-
Enterprise Value	50	21	46	77	133	107	122	205	118	135	35
PE Ratio	-1.48	-1.48	-3.62	-6.90	-16.17	-5.68	-12.48	-12.21	-9.69	-8.13	-
PS Ratio	-	-	34.35	22.37	21.43	36.84	8.68	677.67	249.98	430.55	-
PB Ratio	-1.22	-1.22	-6.45	-9.20	-1.72	-2.08	-1.30	-1.31	-1.74	-2.87	-
P/FCF Ratio	-1.58	-1.58	-4.32	-4.64	-7.63	-4.47	-4.02	-4.42	-3.28	-6.04	-
P/OCF Ratio	-1.58	-1.58	-4.33	-4.64	-7.63	-4.42	-4.02	-4.43	-3.29	-6.05	-
EV/Sales Ratio	-	-	22.63	19.25	20.67	38.77	9.81	704.02	186.18	260.98	22.37
EV/EBITDA Ratio	-1.05	-1.05	-2.42	-6.04	-17.19	-9.67	-29.03	-16.99	-7.52	-5.37	-1.19
EV/EBIT Ratio	-1.05	-1.05	-2.41	-6.00	-16.98	-9.64	-27.60	-16.72	-7.40	-5.27	-1.15
EV/FCF Ratio	-1.11	-1.11	-2.85	-3.99	-7.37	-4.71	-4.54	-4.60	-2.44	-3.66	-1.14
Debt / Equity Ratio	-0.02	-0.02	-0.07	-0.10	-0.01	-0.15	-0.19	-0.13	-0.12	-	-0.07
Debt / EBITDA Ratio	-0.03	-0.03	-0.04	-0.07	-0.12	-0.64	-3.74	-1.62	-0.70	-	-1.24
Debt / FCF Ratio	-0.03	-0.03	-0.04	-0.05	-0.05	-0.31	-0.59	-0.44	-0.23	-	-1.19
Quick Ratio	0.90	0.90	3.18	1.59	0.92	0.13	0.09	0.74	4.50	11.40	0.34
Current Ratio	1.00	1.00	3.52	1.84	1.13	0.21	0.18	0.76	4.56	11.54	0.24
Asset Turnover	0	0	0.06	0.17	0.64	0.29	1.09	0.01	0.01	0.01	-
Interest Coverage	-1556.69	-1556.69	-1263.27	-1071.67	-11.28	-6.08	-1.34	-3.96	-40.09	-14.49	-5.00
Return on Equity (ROE)	85.80%	85.80%	174.50%	38.40%	12.90%	35.20%	10.00%	12.50%	19.00%	45.90%	-
Return on Assets (ROA)	-104.90%	-104.90%	-60.90%	-54.50%	-85.30%	-187.60%	-75.90%	-47.50%	-25.60%	-48.70%	-
Return on Capital (ROIC)	103.22%	103.22%	215.42%	227.67%	15.31%	47.88%	29.53%	38.70%	68.87%	48.92%	6.25%
Earnings Yield	-34.62%	-67.35%	-27.65%	-14.50%	-6.18%	-17.59%	-8.01%	-8.19%	-10.32%	-12.31%	-
FCF Yield	-32.62%	-63.46%	-23.15%	-21.55%	-13.10%	-22.37%	-24.87%	-22.61%	-30.47%	-16.57%	-
Buyback Yield / Dilution	-	-16.15%	-21.87%	-23.33%	-47.01%	-24.18%	-	-	-	-
Total Shareholder Return	-	-16.15%	-21.87%	-23.33%	-47.01%	-24.18%	-	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).